The left-side group of mice is a control—with neither the gene-editing RNA nor the BOC switch. The next group has BOC but no RNA

Biological Switch May Offer Better Control of Gene Editing

Team invents biological switch that turns protein expression on at will
According to Lotta Ljungqvist

GE Healthcare, Swedish Government Open an Innovation Center in Uppsala

Testa Center focuses on advancing manufacturing capabilities and the commercialization of new technologies in life sciences, aligning with Sweden's goals of strengthening its capacity for innovation and thus its economic competitiveness.
Transmembrane proteins with multiple membrane-spanning regions have been designed by computer and shown to be highly stable when embedded in the plasma membrane in bacteria and mammalian cells. In this image

Designer Multipass Transmembrane Proteins the Latest Cellwear

Transmembrane proteins with multiple membrane-spanning regions have been designed by computer and shown to be highly stable when embedded in the plasma membrane in bacteria and mammalian cells

LGLS Licenses Novavax’ VLP Technology to Develop Flu Vaccines for South Korea and Other...

Firm will build VLP vaccine manufacturing plant and will also develop flu vaccines for other emerging markets.

Five Life Sciences Researchers Win Breakthrough Prizes Totaling $15M

Five life sciences researchers have been honored as winners of the 2018 Breakthrough Prize in Life Sciences, which honors “transformative” advances toward understanding living systems and extending human life.
Cardiovascular disease is alleviated by an engineered protein

Stroke, Heart Attack Damage Could Be Mitigated via Mimicry of Good Cholesterol

Cardiovascular disease is alleviated by an engineered protein, a stable version of a chaperone protein found in good cholesterol, that helps suppress inflammation, lower blood pressure, and reverse tissue damage in mouse models

Lonza to Leverage IDBS’ Data Management and Execution Solution

Bioprocess Execution System will will allow storing of data in context and more efficient sharing between groups.
GE Healthcare's "factory-in-a-box.

Factory in a Box Launched for Production of Viral Vector–Based Therapeutics

Factory in a box products include vaccines, oncolytic viruses, and gene and cell therapies.

CSL Behring Plans $450M Expansion of Illinois, Australia Sites

Projects will add capacity to produce plasma intermediates in Kankakee, IL, site, and albumin in Melbourne

GenVec and Novartis Cement Hearing Loss Partnership with Manufacturing Deal

Firms aim to develop GenVec’s gene-based therapy for restoring hearing and balance.

Recently Featured

Scroll Up